Payoneer Global Inc vs Roivant Sciences Ltd. Common Shares — how do they compare? Payoneer Global Inc trades at $7.15 (market cap $2.43B), while Roivant Sciences Ltd. Common Shares trades at $35.16 (market cap $24.72B). The key difference: Roivant Sciences Ltd. Common Shares is far larger — about 10.2× Payoneer Global Inc's market cap, and Payoneer Global Inc is trading nearer its 52-week high, Roivant Sciences Ltd. Common Shares nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Payoneer Global Inc for 61 Days and Roivant Sciences Ltd. Common Shares for 0 Days on average.
| PAYO | ROIV | |
|---|---|---|
Market Cap | $2.43B | $24.72B |
Volume | 1,342,701 | 6,279,442 |
Sector | Technology | Health |
52-Week High | $7.18 | $41.81 |
52-Week Low | $4.27 | $16.04 |
Typical Hold Time | 61 Days | 0 Days |
Enterprise Value | $2.17B | $20.99B |
Signals from Pluang's Aura AI — not financial advice
Payoneer Global (PAYO) trades at $7.15, down slightly by 0.14% with a bullish technical signal from moving averages. The company reported Q2 2026 earnings of $0.02 per share, missing estimates, but revenue grew 10% excluding interest. Recent news highlights Payoneer's renewed partnership with Etsy through 2029 and the company's agreement to be acquired by Nuvei announced in June 2026. Analyst sentiment remains positive with 60% buy ratings despite recent earnings volatility.
The acquisition by Nuvei creates near-term upside potential, but execution risks and margin compression pose challenges. Revenue growth remains solid at 15% volume growth year-over-year, though net income margin has declined from 16.8% in 2024 to 5.8% projected for 2026. The stock's valuation at 51x P/E appears stretched relative to earnings growth, suggesting cautious optimism is warranted.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Payoneer Global Inc is the world's go-to partner for digital commerce, everywhere. The company started as a cross-border payments platform that empowers businesses, online sellers, and freelancers. The platform allows the users to get paid in multiple currencies, bill global clients, and sell on marketplaces worldwide.
Read more on PAYO →Roivant Sciences develops medicines by building and supporting biotechnology subsidiaries, known as Vants. Its programs span areas such as immunology, neuroscience, and rare diseases.
Read more on ROIV →